Q2 FY26 Results: Net Loss of ₹349L; H1 Profit Boosted by One-Time Ebix Settlement

Emphasis Of MatterResults RestatedRelated Party TransactionsResults View source PDF

VIKASLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.6%1-day move

₹1.65

prior close

₹1.68

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-3.6-1.8-3.6-4.2-0.6-3.0-2.4-3.0-3.6-4.8-7.3-12.1-9.7-20.6

Up moveDown movePending

AI summary

Board approved Q2/H1 FY26 unaudited results (ended Sep 30, 2025). Q2 standalone revenue rose to ₹14,097.78L (vs ₹13,035.63L YoY) but posted a net loss of ₹349.41L. H1 net profit of ₹12,414.82L is largely driven by a one-time ~₹13,030L gain from the Ebix UK settlement (51% equity received by VLL after consortium default). Auditor flagged emphasis of matter on pending regulatory approvals for the Ebix transaction, restatement of Q1 FY26 results (turning a loss into a profit), and material related party transactions awaiting shareholder approval. Board also cleared a postal ballot addendum to seek member approval for RPTs and other routine transactions.

Likely market impact

Q2 shows operating loss; H1 profit is one-time settlement, not core business. Auditor flags RPT compliance gaps and prior restatement, raising governance concerns.